PL360941A1 - Kompozycja miejscowa zawierająca co najmniej jedną witaminę D lub jeden analog witaminy D i co najmniej jeden kortykosteroid - Google Patents

Kompozycja miejscowa zawierająca co najmniej jedną witaminę D lub jeden analog witaminy D i co najmniej jeden kortykosteroid

Info

Publication number
PL360941A1
PL360941A1 PL36094101A PL36094101A PL360941A1 PL 360941 A1 PL360941 A1 PL 360941A1 PL 36094101 A PL36094101 A PL 36094101A PL 36094101 A PL36094101 A PL 36094101A PL 360941 A1 PL360941 A1 PL 360941A1
Authority
PL
Poland
Prior art keywords
vitamin
corticosteroid
analogue
composition containing
topical composition
Prior art date
Application number
PL36094101A
Other languages
English (en)
Other versions
PL212660B1 (pl
Inventor
Gert Hoy
Erik Johannes Didriksen
Original Assignee
Leo Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL360941(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leo Pharma A/S filed Critical Leo Pharma A/S
Publication of PL360941A1 publication Critical patent/PL360941A1/pl
Publication of PL212660B1 publication Critical patent/PL212660B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL360941A 2000-10-27 2001-09-26 Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie PL212660B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24347100P 2000-10-27 2000-10-27
PCT/DK2001/000613 WO2002034235A1 (en) 2000-10-27 2001-09-26 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid

Publications (2)

Publication Number Publication Date
PL360941A1 true PL360941A1 (pl) 2004-09-20
PL212660B1 PL212660B1 (pl) 2012-11-30

Family

ID=22918889

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360941A PL212660B1 (pl) 2000-10-27 2001-09-26 Zasadniczo niewodna zelowa kompozycja farmaceutyczna do podawania na skóre oraz jej zastosowanie

Country Status (21)

Country Link
US (1) US6787529B2 (pl)
EP (1) EP1331927B1 (pl)
JP (3) JP4451061B2 (pl)
KR (1) KR100844285B1 (pl)
CN (1) CN100382803C (pl)
AT (1) ATE380542T1 (pl)
AU (2) AU9163701A (pl)
BR (1) BRPI0114927B8 (pl)
CA (1) CA2423930C (pl)
CY (1) CY1107294T1 (pl)
CZ (1) CZ305984B6 (pl)
DE (1) DE60131881T2 (pl)
DK (1) DK1331927T3 (pl)
ES (1) ES2298264T3 (pl)
HU (1) HU230005B1 (pl)
IL (2) IL154888A0 (pl)
MX (1) MXPA03003511A (pl)
PL (1) PL212660B1 (pl)
PT (1) PT1331927E (pl)
RU (1) RU2271810C2 (pl)
WO (1) WO2002034235A1 (pl)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US20090098065A1 (en) * 2000-01-11 2009-04-16 Avikam Harel Composition and methods for the treatment of skin disorders
PT1331927E (pt) * 2000-10-27 2008-01-30 Leo Pharma As Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide
US20090143328A1 (en) * 2001-08-13 2009-06-04 Mcdonald George Method of Treating Cancer by Administration of Topical Active Corticosteroids
BR0315195A (pt) * 2002-12-17 2005-08-23 Galderma Sa Composições farmacêuticas e usos das composições
FR2854802B1 (fr) * 2003-05-12 2005-06-24 Galderma Res & Dev Procede de preparation d'une formulation contenant un principe actif microdose
US8404667B2 (en) * 2006-12-29 2013-03-26 Wisconsin Alumni Research Foundation Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog
FR2871693B1 (fr) * 2004-06-17 2006-08-25 Galderma Sa Utilisation d'une composition pharmaceutique comprenant du calcitriol et du propionate de clobetasol pour le traitement du psoriasis
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
FR2871697B1 (fr) * 2004-06-17 2007-06-29 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
EP1781302A4 (en) * 2004-07-28 2010-02-17 Lipopeptide Ab NEW USE
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CA2608023C (en) * 2005-05-10 2015-08-18 Dermipsor Ltd. Compositions comprising calcipotriol and nicotinamide for treating hyperproliferative epidermal diseases
CA2611147C (en) 2005-06-01 2013-04-09 Stiefel Research Australia Pty Ltd. Topical emulsion formulation
BRPI0613230A2 (pt) * 2005-06-10 2011-01-04 Galderma Sa método para a liberação controlada de uma droga, método de administração, método de tratamento de distúrbios da pele, composição de liberação controlada e uso de uma composição
MXPA05009381A (es) * 2005-09-02 2007-03-01 Fernando Ahumada Ayala Preparaciones para el cuidado de la piel que contienen mupirocina y dipropionato de betametasona.
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
BRPI0621471A2 (pt) 2006-03-17 2012-09-11 Leo Pharma As métodos de isomerização de uma solução de um derivado de vitamina d, para produzir e preparar calcipotriol ou monoidrato de calcipotriol, e para a fabricação de uma formulação farmacêutica ou medicamento, e, uso de um reator foto-reator de fluxo direto ou foto-reator de fluxo contìnuo
KR20090039833A (ko) * 2006-08-29 2009-04-22 테바 파마슈티컬 인더스트리즈 리미티드 비타민 ｄ 및 코르티코스테로이드를 포함하는 약학 조성물
FR2909284B1 (fr) 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
ES2272198B1 (es) * 2006-12-28 2008-06-01 Laboratorios Viñas S.A. Procedimiento para la obtencion de hidrato de calcipotriol.
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970048A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D
EP2008651A1 (en) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited A bioerodible patch
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US9254296B2 (en) * 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
MX2012007229A (es) * 2009-12-22 2012-07-30 Leo Pharma As Composicion cutanea que comprende analogo de vitamina d y mezcla de solvente y tensioactivos.
JP5816194B2 (ja) * 2009-12-22 2015-11-18 レオ ファーマ アクティーゼルスカブ カルシポトリオール一水和物ナノクリスタル
SI2579852T1 (sl) 2010-06-11 2015-03-31 Leo Pharma A/S Farmacevtski sprej sestavek obsegajoäś vitamin d analog in kortikosteroid
RU2429818C1 (ru) * 2010-06-28 2011-09-27 Государственное учреждение здравоохранения "Кемеровская областная клиническая больница" Лечебное средство
RU2442565C1 (ru) * 2010-08-27 2012-02-20 Государственное учреждение здравоохранения "Кемеровская областная клиническая больница" Лечебная мазь
US8685381B2 (en) * 2010-10-23 2014-04-01 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
US8968755B2 (en) 2010-10-23 2015-03-03 Joel Schlessinger Topical base and active agent-containing compositions, and methods for improving and treating skin
CN103533962B (zh) 2011-03-14 2018-05-18 药品配送方案有限公司 一种眼用组合物
JP5897299B2 (ja) * 2011-10-14 2016-03-30 岩城製薬株式会社 ローション剤
CN104138352B (zh) * 2013-04-19 2018-02-27 江苏知原药业有限公司 卡泊三醇非水凝胶
TW201636025A (zh) * 2015-04-15 2016-10-16 Maruho Kk 皮膚用之醫藥組成物
LT3310389T (lt) * 2015-06-18 2020-11-10 Bausch Health Ireland Limited Vietinio vartojimo kompozicijos, apimančios kortikosteroidą ir retinoidą, skirtos psoriazės gydymui
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
KR102354028B1 (ko) 2020-05-13 2022-01-24 동국대학교 경주캠퍼스 산학협력단 건선 예방, 개선 또는 치료용 피부 외용제 조성물
CN114159567B (zh) * 2020-09-10 2023-03-31 南京海融医药科技股份有限公司 一种治疗皮肤病的混悬凝胶剂
CN115569199B (zh) * 2022-02-14 2024-08-20 海勃(上海)医药科技有限公司 一种药物组合物及其制备方法和应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569935A (en) * 1983-03-17 1986-02-11 University Of Tennessee Research Corp. Topical treatment of psoriasis with imidazole antibiotics
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
SE457055B (sv) * 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
US5002938A (en) 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
DK0437225T3 (da) * 1990-01-10 1994-06-27 Hoffmann La Roche Topiske præparater
US5185150A (en) * 1990-08-24 1993-02-09 Wisconsin Alumni Research Fdn. Cosmetic compositions containing 19-nor-vitamin D compounds
US5763428A (en) * 1990-09-21 1998-06-09 Bone Care International, Inc. Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
JP2571493B2 (ja) * 1992-06-04 1997-01-16 株式会社資生堂 皮膚外用剤
ATE181062T1 (de) * 1992-08-28 1999-06-15 Bone Care Int Inc 1alpha,24(s)-dihydroxy vitamin d2, seine synthese und verwendung
GB9226860D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Novel treatment
DE4328217C2 (de) * 1993-08-21 1996-01-11 Lohmann Therapie Syst Lts Therapeutisches System zur Behandlung der Psoriasis
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
FR2740042B1 (fr) * 1995-10-23 1997-11-14 Oreal Support, et composition contenant ce support et un actif cosmetique ou dermatologique stabilise
JPH10158147A (ja) * 1996-11-29 1998-06-16 Kenji Nakamura 皮膚保護用の被膜組成物とそれを用いた製品
DE59712694D1 (de) * 1997-04-18 2006-08-24 Fritz Stanislaus Stabilisiertes arzneimittel enthaltend cysteinylderivate
JPH11188054A (ja) * 1997-12-25 1999-07-13 Lion Corp 皮膚外用部材
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
FR2785284B1 (fr) * 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
CA2370565C (en) * 1999-04-23 2008-11-25 Leo Pharma A/S Dermally applicable vitamin d-containing pharmaceutical compositions
PT1331927E (pt) * 2000-10-27 2008-01-30 Leo Pharma As Composição tópica contendo pelo menos uma vitamina d ou um análogo de vitamina d e, pelo menos, um corticosteróide

Also Published As

Publication number Publication date
PT1331927E (pt) 2008-01-30
EP1331927B1 (en) 2007-12-12
WO2002034235A1 (en) 2002-05-02
IL154888A0 (en) 2003-10-31
HUP0302881A3 (en) 2012-03-28
DE60131881T2 (de) 2008-12-04
JP5699169B2 (ja) 2015-04-08
BRPI0114927B8 (pt) 2021-05-25
AU2001291637B2 (en) 2006-04-06
BR0114927A (pt) 2003-12-23
US6787529B2 (en) 2004-09-07
DK1331927T3 (da) 2008-05-05
CA2423930C (en) 2009-11-24
BR0114927B1 (pt) 2017-12-05
CY1107294T1 (el) 2012-11-21
KR20030048083A (ko) 2003-06-18
CZ305984B6 (cs) 2016-06-08
CN1633280A (zh) 2005-06-29
EP1331927A1 (en) 2003-08-06
PL212660B1 (pl) 2012-11-30
DE60131881D1 (de) 2008-01-24
CA2423930A1 (en) 2002-05-02
RU2271810C2 (ru) 2006-03-20
MXPA03003511A (es) 2004-05-04
CN100382803C (zh) 2008-04-23
JP5721927B2 (ja) 2015-05-20
HUP0302881A2 (hu) 2003-12-29
JP4451061B2 (ja) 2010-04-14
IL154888A (en) 2013-12-31
KR100844285B1 (ko) 2008-07-09
HK1077208A1 (en) 2006-02-10
ATE380542T1 (de) 2007-12-15
JP2013075924A (ja) 2013-04-25
HU230005B1 (en) 2015-04-28
AU9163701A (en) 2002-05-06
JP2004512297A (ja) 2004-04-22
US20020111336A1 (en) 2002-08-15
JP2008297310A (ja) 2008-12-11
ES2298264T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
YU75701A (sh) Farmaceutski preparat
SE0001899D0 (sv) New compounds
BR0210139A (pt) Composições farmacêuticas
ATE304368T1 (de) Kräuterpflanzen enthaltende artzneimittel
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
WO2004021967A3 (en) Depigmenting composition for the skin comprising adapalene and at least one depigmenting agent
WO2003063824A3 (en) Pharmaceutical composition
AU2002368133A1 (en) 1,3-azole derivative and medicinal composition containing the derivative for treatment for thombosis
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
WO2002004012A8 (en) Anhydrous pharmaceutical composition of vancomycin for topical use
WO2002070537A3 (en) Fusidic acid derivatives
PL355113A1 (pl) Nowe pochodne kwasu fusydowego
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
MD1473F2 (en) Antiherpetic remedy
AU2003202550A1 (en) Pharmaceutical formulations with modified release
GB0128071D0 (en) Medicament
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
AU2001287489A1 (en) New agarofuran derivatives, their preparations, pharmaceutical compositions containing them and their uses as medicaments
ZA200207846B (en) Topical antioxidant vitamin composition for skin care.
ZA200201343B (en) Composition for topical administration comprising 5-methoxypsoralen.
ES2151869A1 (es) Composicion de un producto de aplicacion a la piel.
AU1022201A (en) Novel LTB4 antagonist, method for the production thereof and its use as a medicament
AU3805500A (en) Pharmaceutical preparation containing dithranol